This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: CHD

March 2016 Br J Cardiol 2016;23:10–11

In brief

BJCardio Staff

Abstract

Approval for new heart failure treatment A breakthrough drug for the treatment of chronic heart failure is now available in the UK.  The new drug sacubitril/valsartan (Entresto®, Novartis) has been approved for the treatment of adults with symptomatic heart failure with reduced left ventricular ejection fraction (HFREF). Sacubitril/valsartan – the first drug in the angiotensin receptor neprilysin inhibitor (ARNI) class of drugs – was found to be superior to an evidence-based dose of the angiotensin-converting enzyme (ACE) inhibitor, enalapril, in the PARADIGM-HF study, the largest heart failure study conducted to date. PARADIGM-HF (Pros

| Full text

March 2009 Br J Cardiol 2009;16:80-84

10 steps before you refer for chest pain

Sudhakar Allamsetty, Sreekala Seepana, Kathryn E Griffith

Abstract

(more…)

| Full text

January 2006 Br J Cardiol 2006;13:36-41

Meeting the NSF targets for door-to-needle time in acute myocardial infarction – the role of a bolus thrombolytic

Velmurugan C Kuppuswamy, Daniela Webbe, Sandeep Gupta

Abstract

No content available

| Full text

March 2003

My approach to assessing CHD risk

Rubin Minhas

Abstract

No content available

| Full text

March 2003 Br J Cardiol 2003;10:101-4

Better care without delay: acute myocardial infarction

BJCardio editorial team

Abstract

No content available

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now